BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21902565)

  • 1. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting negative response bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2.
    Dionysus KE; Denney RL; Halfaker DA
    Arch Clin Neuropsychol; 2011 Mar; 26(2):81-8. PubMed ID: 21148668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
    Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent validation of the MMPI-2-RF Somatic/Cognitive and Validity scales in TBI Litigants tested for effort.
    Youngjohn JR; Wershba R; Stevenson M; Sturgeon J; Thomas ML
    Clin Neuropsychol; 2011 Apr; 25(3):463-76. PubMed ID: 21391149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
    Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.
    Whitney KA; Davis JJ; Shepard PH; Herman SM
    Arch Clin Neuropsychol; 2008; 23(7-8):777-86. PubMed ID: 18930375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MMPI-2 validity scale scores of personal injury litigants and disability claimants.
    Tsushima WT; Geling O; Fabrigas J
    Clin Neuropsychol; 2011 Nov; 25(8):1403-14. PubMed ID: 22003896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMPI-2 restructured form over-reporting scales in first-episode psychosis.
    Purdon SE; Purser SM; Goddard KM
    Clin Neuropsychol; 2011 Jul; 25(5):829-42. PubMed ID: 21756212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the MMPI-2 Response Bias Scale and Henry-Heilbronner Index in a U.S. veteran population.
    Young JC; Kearns LA; Roper BL
    Arch Clin Neuropsychol; 2011 Apr; 26(3):194-204. PubMed ID: 21459900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
    Sellbom M; Wygant D; Bagby M
    Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of the Response Bias Scale (RBS) and MMPI-2 validity scales to memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Clin Neuropsychol; 2008 Dec; 22(6):1061-79. PubMed ID: 18609315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a Response Bias Scale (RBS) for the MMPI-2.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Assessment; 2007 Jun; 14(2):196-208. PubMed ID: 17504891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minnesota Multiphasic Personality Inventory-2 revised form Symptom Validity Scale-Revised (MMPI-2-RF FBS-r; also known as Fake Bad Scale): psychometric characteristics in a nonlitigation neuropsychological setting.
    Gass CS; Odland AP
    J Clin Exp Neuropsychol; 2012; 34(6):561-70. PubMed ID: 22384793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the new MMPI-2 Response Bias Scale (Gervais): relationship with MMPI-2 validity scales.
    Nelson NW; Sweet JJ; Heilbronner RL
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):67-72. PubMed ID: 17162723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of response bias and noncredible performance in adult attention-deficit/hyperactivity disorder.
    Young JC; Gross AM
    Arch Clin Neuropsychol; 2011 Apr; 26(3):165-75. PubMed ID: 21441258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutoff Scores for MMPI-2 and MMPI-2-RF Cognitive-Somatic Validity Scales for Psychometrically Defined Malingering Groups in a Military Sample.
    Jones A
    Arch Clin Neuropsychol; 2016 Nov; 31(7):786-801. PubMed ID: 27405640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Lees-Haley Fake Bad Scale, Henry-Heilbronner Index, and restructured clinical scale 1 in identifying noncredible symptom reporting.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C; Stanczak SR
    Clin Neuropsychol; 2008 Sep; 22(5):919-29. PubMed ID: 18756392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.